US PHARMACIST

Scope & Guideline

Advancing Pharmaceutical Knowledge, One Article at a Time

Introduction

Delve into the academic richness of US PHARMACIST with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0148-4818
PublisherJOBSON PUBLISHING LLC
Support Open AccessNo
CountryUnited States
TypeTrade Journal
Converge1979, from 1990 to 1996, from 2007 to 2024
AbbreviationUS PHARM / US Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678

Aims and Scopes

The journal 'US Pharmacist' focuses on advancing the knowledge and practice of pharmacy through a broad range of topics that address current issues, therapeutic advancements, clinical guidelines, and the pharmacist's role in patient care.
  1. Pharmacotherapy and Treatment Guidelines:
    The journal consistently covers pharmacotherapy options and treatment guidelines across various diseases, including chronic conditions, infectious diseases, and mental health disorders, emphasizing evidence-based practices.
  2. Role of Pharmacists in Healthcare:
    A significant focus is placed on the evolving role of pharmacists in patient care, including their involvement in immunizations, managing chronic diseases, and addressing health disparities, showcasing the importance of pharmacists in the healthcare system.
  3. Emerging Therapies and Drug Approvals:
    The journal highlights recent advancements in drug approvals and emerging therapies, particularly for complex conditions such as cancer, diabetes, and infectious diseases, providing pharmacists with the latest information to enhance patient care.
  4. Public Health and Preventive Care:
    Topics related to public health initiatives, preventive care strategies, and health education are prominently featured, reflecting the journal's commitment to improving community health outcomes.
  5. Mental Health and Substance Use Disorders:
    The journal addresses the intersection of mental health and substance use, discussing pharmacological and non-pharmacological interventions, thereby supporting pharmacists in managing these complex issues.
The 'US Pharmacist' journal has shown a dynamic evolution in its focus areas, with several emerging and trending themes reflecting contemporary challenges and advancements in pharmacy practice.
  1. Telehealth and Digital Health Solutions:
    There is a growing emphasis on telehealth and digital health solutions, driven by the COVID-19 pandemic's impact on healthcare delivery, showcasing the importance of pharmacists in virtual care settings.
  2. Pharmacogenomics and Personalized Medicine:
    The trend towards personalized medicine and pharmacogenomics is gaining traction, with increasing discussions on how genetic factors influence drug therapy and patient outcomes, indicating a shift towards precision medicine.
  3. Mental Health Interventions:
    Recent publications highlight a surge in topics related to mental health interventions, reflecting a broader recognition of mental health's importance in overall patient care and the pharmacist's role in managing these conditions.
  4. Health Disparities and Equity:
    Emerging discussions around health disparities and equity emphasize the role of pharmacists in addressing social determinants of health, aligning with national initiatives aimed at reducing healthcare inequities.
  5. Innovations in Chronic Disease Management:
    There is an increasing focus on innovative approaches to managing chronic diseases, particularly through the use of new technologies and therapies, which are crucial for improving patient outcomes.

Declining or Waning

While 'US Pharmacist' has a robust array of topics, some themes appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field of pharmacy and healthcare.
  1. Traditional Infectious Disease Management:
    There has been a noticeable decline in articles specifically focused on traditional infectious disease management, possibly due to the saturation of content in previous years and a shift towards more innovative and complex therapeutic discussions.
  2. General Nutritional Supplements:
    The frequency of articles discussing general nutritional supplements has decreased, suggesting a possible waning interest as pharmacists increasingly focus on evidence-based pharmacotherapy over supplementation.
  3. Basic Patient Education Topics:
    Basic patient education topics, while still important, are less frequently covered as the journal shifts to more advanced and specialized content that addresses complex pharmaceutical care issues.

Similar Journals

Exploratory Research in Clinical and Social Pharmacy

Exploring the intersection of clinical and social pharmacy.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Canadian Pharmacists Journal

Connecting research and practice for safer medication use.
Publisher: SAGE PUBLICATIONS INCISSN: 1715-1635Frequency: 6 issues/year

The Canadian Pharmacists Journal, published by SAGE Publications Inc, serves as a pivotal platform for advancing research and dialogue within the fields of Pharmaceutical Science and Pharmacy. With an ISSN of 1715-1635 and an E-ISSN of 1913-701X, this esteemed journal has demonstrated its commitment to excellence, securing a notable Q2 ranking in both categories as of 2023. Researchers and practitioners can access a wealth of knowledge from its publications, reflecting innovative practices and foundational studies in the realm of pharmacy. The journal's scope is expansive, targeting key issues that drive the evolution of pharmaceutical practices in Canada and beyond, making it an indispensable resource for pharmacists, healthcare professionals, and students dedicated to the advancement of patient care and medication safety. Its dedicated insights and analyses are vital for fostering a deeper understanding of the dynamic landscape of pharmacy, ensuring that it remains a crucial reference point for all stakeholders in the field.

Turkish Journal of Pharmaceutical Sciences

Shaping the Future of Healthcare Through Research
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

Pharmacy

Innovating drug development through open-access research.
Publisher: MDPIISSN: Frequency: 6 issues/year

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.

Integrated Pharmacy Research and Practice

Uniting research and practice to elevate pharmaceutical standards.
Publisher: DOVE MEDICAL PRESS LTDISSN: 2230-5254Frequency: 1 issue/year

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

Pharmacy Practice-Granada

Fostering collaboration to elevate pharmacy education and practice.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

Asian Journal of Pharmaceutical Research and Health Care

Exploring New Frontiers in Health and Pharmacology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2250-1444Frequency: 4 issues/year

Asian Journal of Pharmaceutical Research and Health Care, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating cutting-edge research in the fields of pharmacology, toxicology, and healthcare. With an ISSN of 2250-1444 and an E-ISSN of 2250-1460, this journal aims to provide valuable insights and advancements in pharmaceutical sciences, targeting researchers, practitioners, and students dedicated to improving health outcomes. Although its coverage in Scopus was discontinued in 2016, the journal maintains importance within the academic community by fostering discourse and sharing knowledge on emerging topics. Despite its challenges reflected in the low Scopus ranking within its category, the Asian Journal of Pharmaceutical Research and Health Care remains committed to enhancing access to critical research and publishing high-quality work that bridges the gap between theory and practice in health care. Researchers and professionals engaged in the pharmaceutical field are encouraged to contribute and leverage this journal as a means to advance their work and elevate healthcare standards in Asia and beyond.

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE

Championing excellence in pharmacy practice and education.
Publisher: OXFORD UNIV PRESSISSN: 0961-7671Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE is a distinguished peer-reviewed journal published by Oxford University Press that has been serving the pharmacy and healthcare community since 1991. With the ISSN 0961-7671 and E-ISSN 2042-7174, the journal aims to advance the field of pharmacy practice through the dissemination of high-quality research and innovative practices. The journal is recognized for its impactful contributions, holding a Q1 status in Pharmacy and laying within the Q2 to Q3 quartiles across various health-related categories in 2023, underscoring its commitment to excellence. It occupies a notable position within Scopus rankings, most prominently within the Health Professions: Pharmacy category, where it ranks 12th out of 45 journals, reflecting its relevance and significance in the field. Scholars and practitioners benefit from the journal's rich repository of knowledge that encompasses diverse topics, including pharmaceutical sciences and health policy, supporting the development and enhancement of pharmacy practices worldwide. Although it is not an open-access journal, it continues to be a crucial resource for professionals and academics seeking to stay at the forefront of pharmacy practice advancements.

ANNALS OF INTERNAL MEDICINE

Transforming Healthcare through Evidence-Based Knowledge
Publisher: AMER COLL PHYSICIANSISSN: 0003-4819Frequency: 12 issues/year

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

CURRENT OPINION IN PEDIATRICS

Empowering professionals with the latest pediatric perspectives.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8703Frequency: 6 issues/year

CURRENT OPINION IN PEDIATRICS, published by Lippincott Williams & Wilkins, is a highly esteemed journal in the realm of pediatrics, maintaining a remarkable Q1 status within the Pediatrics, Perinatology, and Child Health categories. With an impressive ranking of 42 out of 330 in the Scopus database, this journal positions itself at the forefront of pediatric research, embodying the voice of contemporary pediatric thought and innovation. Spanning an expansive publication history since 1989 and envisioned to continue through 2024, it serves as a critical platform for practitioners and researchers seeking the latest insights and opinions shaping child health practices. As a non-open access journal, it provides a curated collection of expert reviews, designed to facilitate informed decision-making among professionals while integrating emerging research findings into everyday pediatric care. With an emphasis on exceptional quality and contribution to the field, CURRENT OPINION IN PEDIATRICS is essential reading for anyone dedicated to enhancing child health outcomes.